When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CARA - Is Cara Therapeutics Stock a Buy After Its First FDA Drug Approval
Cara Therapeutics Inc.
Cara Therapeutics (NASDAQ: CARA) recently scored a key win with Food and Drug Administration approval of Korsuva in treating pruritis associated with chronic kidney disease for patients on hemodialysis. In this Motley Fool Live video recorded on Aug. 25, 2021 , Motley Fool contributors Keith Speights and Brian Orelli discuss whether or not Cara stock is a buy after the big news.